Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dianqi Hou"'
Autor:
Dandan Gao, Qiangyi Zhou, Dianqi Hou, Xiaoqing Zhang, Yiqin Ge, Qingwei Zhu, Jian Yin, Xiangqian Qi, Yaohua Liu, Meiqing Lou, Li Zhou, Yunke Bi
Publikováno v:
PeerJ, Vol 12, p e16874 (2024)
Low-grade glioma (LGG), a common primary tumor, mainly originates from astrocytes and oligodendrocytes. Increasing evidence has shown that peroxisomes function in the regulation of tumorigenesis and development of cancer. However, the prognostic valu
Externí odkaz:
https://doaj.org/article/e1101c8670c644159f329f04b497971f
Autor:
Yang Jiang, Jinpeng Zhou, Dan Zou, Dianqi Hou, Haiying Zhang, Junshuang Zhao, Long Li, Jiangfeng Hu, Ye Zhang, Zhitao Jing
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 36-48 (2019)
Background: Glioma is the most common primary malignant tumor in the central nervous system with frequent hypoxia and angiogenesis. Limb-Bud and Heart (LBH) is a highly conserved transcription cofactor that participates in embryonic development and t
Externí odkaz:
https://doaj.org/article/fe04e8a368d74573aa64dd7f954d9c6d
Autor:
Yang Jiang, Jinpeng Zhou, Junshuang Zhao, Dianqi Hou, Haiying Zhang, Long Li, Dan Zou, Jiangfeng Hu, Ye Zhang, Zhitao Jing
Publikováno v:
EBioMedicine, Vol 52, Iss , Pp - (2020)
Background: Glioma has a poor prognosis, and is the most common primary and lethal primary malignant tumor in the central nervous system. Retinoic acid receptor-related orphan receptor A (RORA) is a member of the ROR subfamily of orphan receptors and
Externí odkaz:
https://doaj.org/article/ebb56009cd4547d58164cdce563c67b3
Publikováno v:
Journal of Cancer. 13:1664-1678
background: Glioblastoma Multiform (GBM) is the primary malignancy with the highest incidence and worst prognosis in the adult CNS. Circular RNAs (circRNAs) are a novel and widely diverse class of endogenous non-coding RNAs that can promote or inhibi
Autor:
Jinpeng Zhou, Long Li, Yang Jiang, Haiying Zhang, Ye Zhang, Peng Luo, Yin-Sheng Chen, Yanju Ma, Dianqi Hou, Zhitao Jing, Dan Zou, Huiling Gao
Publikováno v:
The Journal of Pathology. 249:26-38
Mesenchymal glioblastoma (GBM) is the most aggressive subtype of GBM. Our previous study found that neurotrophic factor prosaposin (PSAP) is highly expressed and secreted in glioma and can promote the growth of glioma. The role of PSAP in mesenchymal
Autor:
Zhitao Jing, Haiying Zhang, Dan Zou, Ye Zhang, Jiangfeng Hu, Dianqi Hou, Jinpeng Zhou, Junshuang Zhao, Long Li, Yang Jiang
Publikováno v:
EBioMedicine
EBioMedicine, Vol 52, Iss, Pp-(2020)
EBioMedicine, Vol 52, Iss, Pp-(2020)
Background: Glioma has a poor prognosis, and is the most common primary and lethal primary malignant tumor in the central nervous system. Retinoic acid receptor-related orphan receptor A (RORA) is a member of the ROR subfamily of orphan receptors and
Autor:
Jiangfeng Hu, Haiying Zhang, Jinpeng Zhou, Junshuang Zhao, Dianqi Hou, Long Li, Yang Jiang, Dan Zou, Zhitao Jing, Ye Zhang
Publikováno v:
EBioMedicine, Vol 48, Iss, Pp 36-48 (2019)
EBioMedicine
EBioMedicine
Background: Glioma is the most common primary malignant tumor in the central nervous system with frequent hypoxia and angiogenesis. Limb-bud and heart (LBH) is a highly conserved transcription cofactor that participates in embryonic development and t
Autor:
Long Li, Yang Jiang, Haiying Zhang, Ye Zhang, Junshuang Zhao, Dianqi Hou, Jiangfeng Hu, Dan Zou, Zhitao Jing, Jinpeng Zhou
Publikováno v:
SSRN Electronic Journal.
Background: Glioma is the most common primary and lethal primary malignant tumor in central nervous system with poor prognosis. Retinoic acid receptor-related orphan receptor A (RORA) is a member of ROR subfamily of orphan receptors and plays anti-tu
Autor:
Weiwei Dai, Shiming Ju, Heli Cao, Gan Wang, Dianqi Hou, Shiwen Chen, Zhiqiang Li, Heng-Li Tian, Wen-Wei Gao, Xu-Yang Wang, Yan Guo, Lin Zhang
Publikováno v:
Molecular Informatics. 35:262-267
Rho-kinase dimerization is essential for its kinase activity and biological function; disruption of the dimerization has recently been established as a new and promising therapeutics strategy for cerebrovascular malformation (CM). Based on Rho-kinase